Skip to main
PLXS
PLXS logo

Plexus (PLXS) Stock Forecast & Price Target

Plexus (PLXS) Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 67%
Buy 0%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Plexus Corp demonstrated a positive financial trajectory, achieving 5% year-over-year growth in its Healthcare/Life Sciences (HCLS) segment, amounting to $1.629 billion in annual revenue, with expectations for further increases driven by multiple program ramps and improving customer demand. The Aerospace and Defense (A&D) segment is projected to experience mid-single-digit quarter-over-quarter growth, bolstered by developments in commercial air and defense, indicating alignment with the company's overall revenue growth goal of 9-12% for FY26. Additionally, excluding restructuring charges, earnings growth is expected to significantly outpace revenue growth, reflecting the efficacy of Plexus's strategic initiatives and potential for continued operational leverage.

Bears say

Plexus Corp has experienced a decline in gross margin from 10.1% to 9.9%, indicating pressure on profitability despite stable operating margins, signaling potential concerns regarding cost management. Additionally, revenue from the Aerospace and Defense segment, which constitutes 16% of total revenues, decreased by 6% year-over-year and quarter-over-quarter, reflecting a trend of weakening demand in key sectors. The company faces broader economic headwinds from a potential slowdown in global growth, alongside specific risks related to manufacturing disruptions and competitive pressures, impacting its ability to differentiate itself in a challenging market environment.

Plexus (PLXS) has been analyzed by 3 analysts, with a consensus rating of Buy. 67% of analysts recommend a Strong Buy, 0% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Plexus and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Plexus (PLXS) Forecast

Analysts have given Plexus (PLXS) a Buy based on their latest research and market trends.

According to 3 analysts, Plexus (PLXS) has a Buy consensus rating as of Dec 15, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $160, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $160, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Plexus (PLXS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.